|
|
||||||||
1 Laboratory of Medicine, 2 Department of Internal Medicine, and 3 Institute of Physiology, College of Medicine, National Taiwan University, Taipei 100, Taiwan, Republic of China
| |
ABSTRACT |
|---|
|
|
|---|
Epidermal growth factor (EGF) stimulates the Na+-H+ exchanger, leading to enhanced cell proliferation. In human pleural mesothelial cells (PMCs), the intracellular signaling mechanism mediating the EGF-induced stimulation of the Na+-H+ exchanger has not yet been identified. Using a pH-sensitive fluorescent probe, 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein, to measure changes in intracellular pH (pHi), we found that 1) EGF and 12-O-tetradecanoylphorbol 13-acetate (TPA; a phorbol ester) both stimulate the ethylisopropyl amiloride-sensitive Na+-H+ exchanger; 2) TPA-induced alkalosis can be blocked by protein kinase C (PKC) inhibitors (chelerythrine and staurosporine) or by PKC downregulation, indicating that PKC activation is involved in the stimulation of the Na+-H+ exchanger. However, TPA-induced alkalosis is not blocked by tyrosine kinase inhibitors; and 3) the stimulatory effect of EGF on the Na+-H+ exchanger acts via stimulation of tyrosine kinase-receptor activity because it is inhibited by tyrosine kinase inhibitors (genistein, lavendustin A, and herbimycin A). It also involves PKC activation because EGF-induced alkalosis was blocked by PKC inhibitors. These results suggest that PKC activation is one of the downstream signals for EGF-induced activation of the Na+-H+ exchanger in primary cultures of human pleural mesothelial cells.
tyrosine kinase; epidermal growth factor; protein kinase C; sodium-hydrogen exchanger
| |
INTRODUCTION |
|---|
|
|
|---|
MESOTHELIAL CELLS, which cover the surface of the parietal and visceral pleura, respond to both intrinsic stimuli, such as growth factors, and extrinsic stimuli, such as asbestos fibers (2). Some pleural diseases, including parapneumonic effusion, lupus, pleurisy, and metastatic malignancy, result in the loss of mesothelial integrity and the subsequent accumulation of pleural fluid, with an increase in permeability (15). Cell proliferation in response to growth factors contained in the pleural fluid may therefore be important in restoring the normal mesothelium after pleural injury.
The housekeeping Na+-H+ exchanger isoform 1 (NHE1) is amiloride and ethylisopropyl amiloride (EIPA) sensitive and is expressed in most eukaryotic cells. It is usually activated when the intracellular pH (pHi) falls and exchanges external Na+ for internal H+. It appears to be involved in multiple cellular functions including pHi regulation, transepithelial transport, and cell volume control (13). Moreover, this exchanger can be rapidly activated by various mitogenic factors such as growth factors [e.g., epidermal growth factor (EGF)] and phorbol esters [e.g., 12-O-tetradecanoylphorbol 13-acetate (TPA)], resulting in DNA synthesis and cell proliferation (8, 13, 27, 35).
At least two major mechanisms have been proposed to be involved in the
activation of the
Na+-H+
exchanger by various stimulants. The first is a protein kinase C
(PKC)-dependent pathway involving either G protein-activated phospholipase C (PLC)-
1 or tyrosine kinase receptor-activated PLC-
1 (11, 19); activation of either system leads to the production
of inositol 1,4,5-trisphosphate and diacylglycerol (5), and the latter
then activates PKC, resulting in PKC translocation from the cytosol to
the membrane. This membrane association-activation event can be
mimicked by phorbol esters such as TPA, resulting in the irreversible
insertion of PKC into the lipid bilayer (24). In fibroblasts, it has
been shown that addition of phorbol esters or growth factors increases
the phosphorylation of the
Na+-H+
exchanger (31), thereby leading to an alkaline shift in the resting
pHi that can easily be detected
under nominally bicarbonate-free conditions. Recent studies (34, 35)
have also shown that deletion of all the major potential
phosphorylation sites only resulted in a 50% decrease in exchanger
activation in response to phorbol esters or growth factors, suggesting
that PKC and growth factors do not activate the exchanger exclusively
by direct phosphorylation (34, 35).
The second mechanism is a PKC-independent pathway in which the Na+-H+ exchanger is activated either by growth factors that stimulate the tyrosine kinase receptor (3, 10, 12, 35) or by Ca2+- and/or calmodulin-dependent disinhibition of the exchanger (6, 21, 33, 35). There is evidence that, rather than directly phosphorylating the Na+-H+ exchanger, tyrosine kinase phosphorylates an ancillary protein, and the latter then activates the exchanger, resulting in the modulation of a critical cytoplasmic region and the alteration of the "set point" of the exchanger, leading to intracellular alkalosis (34, 35).
In a previous study (16), we showed the housekeeping Na+-H+ exchanger to be one of the three major pHi regulators in cultured human pleural mesothelial cells (PMCs). Human PMCs possess EGF receptors (28), but little is known about the cellular signaling pathway involved in EGF-induced Na+-H+ exchanger activation. Using 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein (BCECF) to continuously monitor pHi in human PMCs, we have found that EGF-stimulated PKC activation, presumably as a result of receptor-linked tyrosine kinase activity, is required for activation of the exchanger.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Chemicals and solutions. Unless otherwise stated, all chemicals were purchased from Sigma (St. Louis, MO) and all experiments were performed in HEPES-buffered solution consisting of (in mM) 130 NaCl, 5.0 KCl, 1.0 MgCl2, 2.0 CaCl2, 10 glucose, and 10 HEPES, pH adjusted to 7.4 at 37°C with NaOH. In Na+-free Tyrode solution, NaCl was totally replaced by 130 mM N-methyl-D-glucamine (NMDG). EGF was purchased from Collaborative Biomedical Products (Bedford, MA); and herbimycin A, lavendustin A, and chelerythrine were purchased from Research Biochemicals International (Natick, MA).
Isolation and cell culture of human PMCs. Human PMCs were obtained from patients with transudative pleural effusion, e.g., patients with liver cirrhosis or heart failure, as described in our previous report (16). Briefly, after removal of red blood cells from the pleural effusion by gradient centrifugation, the pellet was washed once in RPMI 1640, resuspended in the same medium to a volume of 8-10 ml, and seeded in RPMI 1640 containing 10% FCS, 100 U/ml of penicillin, and 100 µg/ml of streptomycin in 75-cm2 vitrogen-coated tissue culture flasks. After 24 h, one-half of the medium was replaced; thereafter, it was completely replaced every 3 days. The mesothelial cell cultures were maintained for 2-3 passages at 37°C in a humidified environment containing 5% CO2. Before pHi measurement, cells were growth arrested by transfer to low-serum medium (0.5% FCS) for another 24 h. PMCs were identified by their characteristic morphological and immunohistochemical features of positive staining for human cytokeratin (types I and II) and vimentin and negative staining for CEA, desmin, and von Willebrand's factor (18).
Measurement of pHi.
Measurement of pHi has been
described in detail in previous work by Wu and colleagues
(36, 37). Briefly, human PMCs, grown on a cover glass, were loaded with
5 µM BCECF-AM (Molecular Probes, Kent, OR) for 20 min at room
temperature in HEPES-buffered solution, then washed with HEPES-buffered
solution, and excited alternately by 490- and 440-nm wavelength light.
The excitation light was transmitted to the cell with a 510-nm dichroic
mirror under the microscope nosepiece, and the resulting fluorescence
was collected by a ×40 oil-immersion lens. The overall sampling
rate was 0.5 Hz. The 530-nm emission ratio (ratio of 490- to 440-nm
excitation) from the intracellular BCECF was calculated and converted
to a linear pH scale (see below) by in situ calibration at pH 4.5 and 9.5 at the end of the experiment using the nigericin technique (29).
The following equation was used to convert the fluorescence ratio into
pHi:
pHi = pK + log[(Rmax
R)/(R
Rmin)] + log(F440 min/F440 max), where pK is the negative log of dissociation constant for the dye
measured at pH 7.16; R is the ratio of the 530-nm fluorescence at
490-nm excitation to that at 440-nm excitation;
Rmax and
Rmin are the maximum and minimum
ratio values, respectively, from the data curve; and
F440 min and
F440 max are the minimum and
maximum fluorescence values, respectively, at 440-nm excitation.
| |
RESULTS |
|---|
|
|
|---|
EGF stimulates the Na+-H+ exchanger in human PMCs. Under nominally bicarbonate-free conditions (i.e., HEPES-buffered medium), the addition of 100 ng/ml of EGF resulted in a slight initial acidosis (0.02 ± 0.01 pH units; n = 6) of the resting pHi, followed by a more marked pHi increase (0.12 ± 0.05 pH units; n = 6 preparations; Fig. 1A, Table 1) similar in magnitude to the EGF-induced alkalosis seen in rat hepatocytes (~0.1 pH unit) (23).
|
|
Tyrosine kinase-receptor activity is involved in the EGF-mediated stimulation of the Na+-H+ exchanger. The EGF signaling pathway is known to act via activation of the tyrosine kinase receptor (5), and the EGF receptor has recently been found in human PMCs (28). We therefore tested whether tyrosine kinase activation is involved in stimulation of the Na+-H+ exchanger. Genistein and lavendustin A are both potent specific blockers of EGF-stimulated tyrosine kinase activity (1, 25). Figure 2, A and B, shows that either 30 µM genistein or 50 µM lavendustin A itself caused a decrease in pHi (Table 1) by an unknown mechanism. However, in the presence of either of these inhibitors, a further decrease in pHi occurred on addition of 100 ng/ml of EGF (Fig. 2, A and B, arrowheads; Table 1). Herbimycin A, which binds to the thiol groups in tyrosine kinase, is another potent blocker. After overnight pretreatment with herbimycin A (0.5 µM), the EGF-mediated stimulatory effect was lost (Fig. 2C, arrowhead; Table 1). These results all indicate that tyrosine kinase activation is involved in the activation of the Na+-H+ exchanger.
|
TPA, a potent phorbol ester, also stimulates the Na+-H+ exchanger. The membrane association-activation event during PKC activation can be mimicked by TPA (24). Figure 3A shows that, on addition of 1 µM TPA, a slight initial acidosis was seen (0.02 ± 0.01 pH units; n = 8 preparations), followed by a significant increase in pHi (0.11 ± 0.03 pH units; n = 8 preparations; Table 2). On removal of all extracellular Na+ (Fig. 3B) or on addition of EIPA (10 µM; Fig. 3C), a pHi decrease was seen due to inhibition of the Na+-H+ exchanger; however, the subsequent addition of TPA (1 µM) induced a greater acidosis (Fig. 3, B and C, arrowheads; Table 2) compared with the control value (Fig. 3A), and the subsequent alkalization was completely abolished (Fig. 3, B and C; Table 2), indicating that the TPA-induced alkalization (Fig. 3A) was due to stimulation of the Na+-H+ exchanger.
|
|
|
PKC activation is required for EGF-mediated stimulation of the
Na+-H+
exchanger.
The above results indicate that activation of either tyrosine kinase or
PKC can result in stimulation of the
Na+-H+
exchanger (Figs. 1-4). PLC-
1 phosphorylation, resulting in PKC stimulation, is one of the downstream signaling pathways for tyrosine kinase-receptor activation (5). Thus the stimulatory effect of EGF on
the
Na+-H+
exchanger is probably due to PKC activation via tyrosine
kinase-receptor phosphorylation of PLC-
1. We used PKC blockers to
test this possibility (Fig. 5,
A-C).
|
|
| |
DISCUSSION |
|---|
|
|
|---|
Activation of the
Na+-H+
exchanger by growth factors, including EGF, was originally thought to
utilize signaling pathways acting directly through tyrosine kinase
because the receptor has intrinsic tyrosine kinase activity (3, 9, 10,
12). An earlier study by Moolenaar et al. (22), however, showed that
when the tyrosine-specific protein kinase was activated by monoclonal
antibodies, the
Na+-H+
exchanger could not be activated, indicating that the
pHi signal could be dissociated
from tyrosine kinase activity. At a later date, growth factor was
suggested to induce tyrosine phosphorylation of PLC-
1, thereby
activating the PKC-dependent pathway (20). Direct support for this
hypothesis has been provided by at least one recent related study by Ma
et al. (19), who used cells expressing platelet-derived growth factor
receptors that lacked the PKC- and phosphatidylinositol
3'-kinase-mediated signaling pathways and showed that both
pathways are required for platelet-derived growth factor-induced
activation of the NHE1 in transfected epithelial cells.
On the basis of the following evidence in human PMCs, we suggest that
PKC activation is also involved in EGF activation of the
Na+-H+
exchanger, possibly due to tyrosine kinase-receptor phosphorylation of
PLC-
1 (19, 20): 1) the
pHi increase induced by EGF or TPA
can be blocked by either EIPA or the use of
Na+-free conditions, indicating
that it is due to activation of the Na+-H+
exchanger by these two mitogens (Figs. 1 and 3, Tables 1 and 2);
2) the TPA-induced alkalosis can be
blocked by PKC inhibitors (chelerythrine and staurosporine) and PKC
downregulation (Fig. 4, Table 2), indicating that PKC is indeed
involved in the activation of the
Na+-H+
exchanger; and 3) the EGF-induced
alkalosis was blocked not only by tyrosine kinase inhibitors
(genistein, lavendustin A, and herbimycin A; Fig. 2, Table 1) but also
by PKC inhibitors (chelerythrine and staurosporine) and PKC
downregulation (Fig. 5,
A-C;
Table 3). Because the tyrosine kinase inhibitors did not block the TPA-mediated activation of the
Na+-H+
exchanger (Fig. 5, D and
E; Table 3), we cannot completely
exclude the possibility that they themselves did not induce an
alkalosis after extended treatment (Fig. 5,
D and
E). However, we found that once the
steady state of the pHi was
reached after addition of these blockers, the
pHi did not change to any great
extent until the end of the experiment (data not shown), suggesting
that the TPA-induced alkalosis seen in Fig. 5,
D and
E, is most probably due to
TPA-mediated activation of the exchanger and that PKC activation is one
of the downstream signals for EGF-mediated activation of the exchanger
in human PMCs, as shown in other cells (19, 20). In the present study,
however, we cannot completely rule out the possibilities that a mutual
effect of tyrosine kinase and PKC activation is simply expressed at the
EGF receptor or that multiple effects of various kinases and
phosphatases may also be involved in the EGF-induced
Na+-H+
exchanger. The upward shift in the resting
pHi produced by the addition of
EGF reflects a change in the set point, which determines the pHi sensitivity of the
exchanger. According to this model, the set point of the
H+ sensor is adjusted upward by
0.15-0.3 pH unit (13), the magnitude of the alkalosis recorded in
the present study.
The molecular mechanism involved in the PKC-mediated activation of the Na+-H+ exchanger is still unclear. In fibroblasts, it has been shown that phorbol esters increase NHE1 phosphorylation (31); therefore, it is possible that PKC directly phosphorylates a serine residue and activates the NHE1. However, with the use of deletion mutants expressed in fibroblasts, a recent study (34) has shown that replacement of this serine residue with alanine results in only a 50% reduction in phorbol ester-induced alkalization, clearly indicating that PKC does not activate the NHE1 by direct phosphorylation (35); therefore multiple effects of various kinases and phosphatases may be involved.
It is interesting that, in the presence of Na+-H+ exchanger blockers or tyrosine kinase and/or PKC inhibitors (Figs. 1-5), although not always statistically significant, a greater pHi decrease was normally seen on addition of EGF and TPA (Tables 1 and 2). Because a small, but consistent, initial pHi decrease was seen on addition of these two mitogens (Figs. 1A and 3A), we suggest that the larger pHi decrease seen after abolition of the alkalization (i.e., activation of the Na+-H+ exchanger) was probably due to unmasking of the initial acidification induced by these two mitogens. However, the mechanism for this initial small pHi decrease seen on the addition of EGF or TPA (Figs. 1A and 3A) is unknown. One possibility is that EGF and TPA cause transient increases in intracellular Ca2+ levels, resulting in displacement of H+ from common buffering sites (32); another is overproduction of H+ (e.g., via stimulation of the metabolism) by the addition of EGF or TPA.
Recently, the EGF receptor has been shown to be present in human PMCs (28) and rat mesothelial cells (15, 26), and its activation stimulates cell proliferation (15, 26). However, the physiological role of EGF-mediated stimulation of the Na+-H+ exchanger, resulting in alkalosis in human PMCs, is not clear. Activation of the Na+-H+ exchanger, resulting in intracellular alkalosis, is a common phenomenon that stimulates cell proliferation in a variety of cell types (8, 13, 27), with small decreases in pHi causing reduced cell proliferation (8) and a rise in pHi being associated with increased cell numbers (4). However, the role of the Na+-H+ exchanger in stimulating cell growth as a result of intracellular alkalosis is still debatable (13) because some studies show that growth factors or phorbol esters fail to induce a detectable rise in pHi in physiological bicarbonate-containing media (7, 13). In such cases, pHi changes induced by the Na+-H+ exchanger are clearly not of significance in the initiation of cell growth. The possibility of the Na+-H+ exchanger being involved in restoring normal human PMCs after pleural injury requires further investigation.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Chiou-Mei Wu for excellent technical help. P.-C. Yang and M.-L. Wu made equal contributions to this paper.
| |
FOOTNOTES |
|---|
This work was supported by National Taiwan University Hospital Grant NTUH.S871008.
Address for reprint requests: M.-L. Wu, Dept. of Physiology, College of Medicine, National Taiwan Univ., No. 1, Sec. 1, Jen-Ai Rd., Taipei 100, Taiwan, ROC.
Received 27 August 1997; accepted in final form 16 January 1998.
| |
REFERENCES |
|---|
|
|
|---|
1.
Akiyama, T.,
J. Ishida,
S. Nakagawa,
H. Ogawara,
S. Watanabe,
N. Itoh,
M. Shibuya,
and
Y. Fukami.
Genistein, a specific inhibitor of tyrosine-specific protein kinases.
J. Biol. Chem.
262:
5592-5595,
1987
2.
Antony, V. B.,
C. L. Owen,
and
K. J. Hadley.
Pleural mesothelial cells stimulated by asbestos release chemotactic activity for neutrophils in vivo.
Am. Rev. Respir. Dis.
139:
199-206,
1989[Medline].
3.
Benos, D. J.,
S. McPherson,
B. H. Hahn,
M. A. Chaikin,
and
E. N. Benveniste.
Cytokines and HIV envelope glycoprotein gp120 stimulates Na+/H+ exchange in astrocytes.
J. Biol. Chem.
269:
13811-13816,
1994
4.
Berk, B. C.,
G. Vallega,
A. J. Muslin,
H. M. Gordon,
M. Canessa,
and
W. Alexande.
Spontaneously hypertensive rat vascular smooth muscle cells in culture exhibit increased growth and Na+/H+ exchange.
J. Clin. Invest.
83:
822-829,
1989.
5.
Berridge, M. J.
Inositol trisphosphate and calcium signaling.
Nature
361:
315-325,
1993[Medline].
6.
Bertrand, B.,
S. Wakabayashi,
T. Ikeda,
J. Pouysségur,
and
M. Shigewa.
The Na+/H+ exchanger isoform 1 (NHE1) is a novel member of the calmodulin-binding proteins.
J. Biol. Chem.
269:
13703-13709,
1994
7.
Bierman, A. J.,
E. J. Cragoe,
S. W. de Laat,
and
W. H. Moolenaar.
Bicarbonate determines cytoplasmic pH and suppresses mitogen-induced alkalization in fibroblastic cells.
J. Biol. Chem.
263:
15253-15256,
1988
8.
Bobik, A.,
A. Grooms,
P. J. Little,
E. J. Cragoe,
and
S. Grinpukel.
Ethylisopropylamiloride-sensitive pH control mechanisms mediate vascular smooth muscle cell growth.
Am. J. Physiol.
260 (Cell Physiol. 29):
C581-C588,
1991
9.
Carpenter, G.
Receptors for epidermal growth factor and other polypeptide mitogens.
Annu. Rev. Biochem.
56:
881-914,
1987[Medline].
10.
Donowitz, M.,
J. L. M. Montgomery,
M. S. Walker,
and
M. E. Cohen.
Brush-border tyrosine phosphorylation stimulates ileal neutral NaCl absorption and brush-border Na+/H+ exchange.
Am. J. Physiol.
266 (Gastrointest. Liver Physiol. 29):
G647-G656,
1994
11.
Etscheid, B. G.,
G. A. Jamieson, Jr.,
K. Toscas,
and
M. L. Villereal.
Loss of bradykinin receptors and TPA-stimulated Na+ influx in SV40-transformed WI-38 cells.
Am. J. Physiol.
259 (Cell Physiol. 28):
C549-C556,
1990
12.
Fukushima, T.,
T. K. Waddell,
S. Grinstein,
G. G. Goss,
J. Orlowski,
and
G. P. Downey.
Na+/H+ exchange activity during phagocytosis in human neutrophils: role of Fc receptors and tyrosine kinase.
J. Cell Biol.
132:
1037-1052,
1996
13.
Grinstein, S.,
D. Rotin,
and
M. J. Mason.
Na+/H+ exchange and growth factor-induced cytosolic pH changes. Role in cellular proliferation.
Biochim. Biophys. Acta
988:
73-97,
1989[Medline].
14.
Herbert, J. M.,
J. M. Augereau,
J. Gleye,
and
J. P. Maffrand.
Chelerythrine is a potent and specific inhibitor of protein kinase C.
Biochem. Biophys. Res. Commun.
172:
993-999,
1990[Medline].
15.
Hott, J. W.,
J. A. Sparks,
S. W. Godbey,
and
V. B. Antony.
Mesothelial cell response to pleural injury: thrombin-induced proliferation and chemotaxis of rat pleural mesothelial cells.
Am. J. Respir. Cell Mol. Biol.
6:
421-425,
1992.
16.
Liaw, Y. S.,
P. C. Yang,
C. J. Yu,
S. H. Kuo,
K. T. Luh,
Y. J. Lin,
and
M. L. Wu.
Intracellular pH regulation in human cultured pleural mesothelial cells.
Am. J. Respir. Crit. Care Med.
155:
597-602,
1997[Abstract].
17.
Kawamoto, S.,
and
H. Hidaka.
1-(5-Isoquinolinesulfonyl)-2-methylpiperazine (H-7) is a selective inhibitor of protein kinase C in rabbit platelets.
Biochem. Biophys. Res. Commun.
125:
258-264,
1984[Medline].
18.
Kuwahara, M.,
M. Kuwahara,
K. E. Bijwaard,
D. M. Gersten,
C. A. Diglio,
and
E. Kagan.
Mesothelial cells produce a chemoattractant for lung fibroblasts: role of fibronectin.
Am. J. Respir. Cell Mol. Biol.
5:
256-264,
1991.
19.
Ma, Y. H.,
H. P. Reusch,
E. Wilson,
J. A. Escobedo,
W. J. Fantl,
L. T. Williams,
and
H. E. Ives.
Activation of Na/H exchange by platelet-derived growth factor involves phosphatidylinositol 3'-kinase and phospholipase C.
J. Biol. Chem.
269:
30734-30739,
1994
20.
Margolis, B.,
S. G. Rhee,
S. Felder,
M. Mervic,
R. Lyall,
A. Levitzki,
A. Ullrich,
A. Zilberstein,
and
J. Schlessinger.
EGF induces tyrosine phosphorylation of phospholipase C-II: a potential mechanism for EGF receptor signaling.
Cell
57:
1101-1107,
1989[Medline].
21.
McSwine, R. L.,
J. Li,
and
M. L. Villereal.
Examination of the role for Ca2+ in regulation and phosphorylation of the Na+/H+ antiporter NHE1 via mitogen and hypertonic stimulation.
J. Cell. Physiol.
168:
8-17,
1996[Medline].
22.
Moolenaar, W. H.,
L. H. K. Defize,
and
S. W. DeLaat.
Ionic signalling by growth factor receptors.
J. Exp. Biol.
124:
359-373,
1986
23.
Moule, S. K.,
and
J. D. McGivan.
Epidermal growth factor and cyclic AMP stimulate Na+/H+ exchange in isolated rat hepatocytes.
Eur. J. Biochem.
187:
677-682,
1990[Medline].
24.
Nelsestuen, G. L.,
and
M. D. Bazzi.
Activation and regulation of protein kinase C enzymes.
J. Bioenerg. Biomembr.
23:
43-61,
1991[Medline].
25.
Onoda, T.,
H. Iinuma,
Y. Sasaki,
M. Hamada,
K. Isshiki,
H. Naganawa,
and
T. Takeuchi.
Isolation of a novel tyrosine kinase inhibitor, lavendustin A, from Streptomyces griseolavendus.
J. Nat. Prod.
52:
1252-1257,
1989[Medline].
26.
Owens, M. W.,
and
S. A. Milligan.
Growth factor modulation of rat pleural mesothelial cell mitogenesis and collagen synthesis. Effects of epidermal growth factor and platelet-derived factor.
Inflammation
18:
77-87,
1994[Medline].
27.
Pouysségur, J.,
A. Franchi,
G. L'Allemain,
and
S. Paris.
Cytosolic pH, a key determinant of growth factor-induced DNA synthesis in quiescent fibroblasts.
FEBS Lett.
190:
115-119,
1985[Medline].
28.
Ramael, M.,
K. Segers,
C. Buysse,
J. van den Bossche,
and
E. van Marck.
Immunohistochemical distribution patterns of epidermal growth factor receptor in malignant mesothelioma and non-neoplastic mesothelium.
Virchows Arch. A Pathol. Anat. Histopathol.
419:
171-175,
1991[Medline].
29.
Rink, T. J.,
R. Y. Tsein,
and
T. Pozzan.
Cytosolic pH and free Mg2+ in lymphocytes.
J. Cell Biol.
95:
189-196,
1982
30.
Sako, T.,
A. I. Tauber,
A. Y. Jeng,
S. H. Yuspa,
and
P. M. Blumberg.
Contrasting actions of staurosporine, a protein kinase C inhibitor, on human neutrophils and primary mouse epidermal cells.
Cancer Res.
48:
4646-4650,
1988
31.
Sardet, C.,
L. Counillon,
A. Franchi,
and
J. Pouysségur.
Growth factors induce phosphorylation of the Na+/H+ antiporter, a glycoprotein of 110 kD.
Science
247:
723-726,
1990
32.
Vaughan-Jones, R. D.,
W. J. Lederer,
and
D. A. Eisner.
Ca2+ ions can affect intracellular pH in mammalian cardiac muscle.
Nature
301:
522-524,
1983[Medline].
33.
Wakabayashi, S.,
B. Bertrand,
T. Ikeda,
J. Pouysségur,
and
M. Shigekawa.
Mutation of calmodulin-binding site renders the Na/H exchanger (NHE1) highly H+-sensitive and Ca2+ regulation-defective.
J. Biol. Chem.
269:
13710-13715,
1994
34.
Wakabayashi, S.,
B. Bertrand,
M. Shigekawa,
P. Fafournoux,
and
J. Pouysségur.
Growth factor activation and "H+-sensing" of the Na+/H+ exchanger isoform 1 (NHE1). Evidence for additional mechanism not requiring direct phosphorylation.
J. Biol. Chem.
269:
5583-5588,
1994
35.
Wakabayashi, S.,
M. Shigekawa,
and
J. Pouysségur.
Molecular physiology of vertebrate Na+/H+ exchangers.
Physiol. Rev.
77:
51-74,
1997
36.
Wu, M.-L.,
M.-L. Tsai,
and
Y.-Z. Tseng.
DIDS-sensitive pHi regulation in single rat cardiac myocytes in nominally HCO3-free conditions.
Circ. Res.
75:
123-132,
1994
37.
Wu, M.-L.,
K.-L. Tsai,
S.-M. Wang,
J.-C. Wu,
B.-S. Wang,
and
Y.-T. Lee.
Mechanism of hydrogen peroxide and hydroxyl free radical-induced intracellular acidification in cultured rat cardiac myoblasts.
Circ. Res.
78:
564-572,
1996
38.
Young, S. P.,
P. J. Parker,
A. Ullrich,
and
S. Stabel.
Down-regulation of protein kinase C is due to an increase rate of degradation.
Biochem. J.
244:
775-779,
1987[Medline].
This article has been cited by other articles:
![]() |
K. Stathopoulou, I. Beis, and C. Gaitanaki MAPK signaling pathways are needed for survival of H9c2 cardiac myoblasts under extracellular alkalosis Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1319 - H1329. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Johnstone, P. F. Speake, and C. P. Sibley Epidermal growth factor and sphingosine-1-phosphate stimulate Na+/H+ exchanger activity in the human placental syncytiotrophoblast Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2007; 293(6): R2290 - R2294. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Fujiwara, K. Higuchi, T. Takashima, M. Hamaguchi, T. Hayakawa, K. Tominaga, T. Watanabe, N. Oshitani, Y. Shimada, and T. Arakawa Roles of epidermal growth factor and Na+/H+ exchanger-1 in esophageal epithelial defense against acid-induced injury Am J Physiol Gastrointest Liver Physiol, April 1, 2006; 290(4): G665 - G673. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Xu, J. F. Collins, L. Bai, P. R. Kiela, R. M. Lynch, and F. K. Ghishan Epidermal growth factor regulation of rat NHE2 gene expression Am J Physiol Cell Physiol, August 1, 2001; 281(2): C504 - C513. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bali, J. Lipecka, A. Edelman, and J. Fritsch Regulation of ClC-2 chloride channels in T84 cells by TGF-{alpha} Am J Physiol Cell Physiol, June 1, 2001; 280(6): C1588 - C1598. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |